News & Analysis on Clinical Trial Services & Contract Research And Development
Government purchasing commitments would discourage industry antibiotic marketing and help developers overcome reluctance to invest in new antimicrobials say drugmakers in Davos.
Catalent will expand its cGMP facility in Japan to bring secondary packaging and clinical supply services to the region.
Johnson Matthey has expanded its UK biocatalysis R&D operations in response to growing drug industry demand.
Currently, more than 85% of trial sites are paid using manual or in-house process, but as the need for CROs increases, so does the need for automated payments, says Clinverse's CEO.
India has 16% of the world’s population, 20% of the disease burden, and has contributed to less than 1.4% of global clinical trials, but the country is looking to fix this imbalance.
Mucosis has been awarded a Wellcome Trust grant of €3.7m ($4m) to help develop a Respiratory Syncytial Virus (RSV) vaccine using its intranasal delivery platform.